Solasia Pharma KK
TSE:4597
Solasia Pharma KK
TSE:4597
Price:
32
JPY
Market Closed
Market Cap:
¥8.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Solasia Pharma KK
TSE:4597
|
JP |
|
Kura Sushi Inc
TSE:2695
|
JP |
|
Cyberloq Technologies Inc
OTC:CLOQ
|
US |
|
Toyo Kanetsu KK
TSE:6369
|
JP |
|
Namoi Cotton Ltd
ASX:NAM
|
AU |
|
L
|
Limelight Networks Inc
XBER:LNK
|
US |
|
BTU Metals Corp
XTSX:BTU
|
CA |
|
Warehouse Group Ltd
NZX:WHS
|
NZ |
|
O
|
Ogaki Kyoritsu Bank Ltd
TSE:8361
|
JP |
|
Industrials REIT Ltd
LSE:MLI
|
UK |
|
G
|
Grande Armee Investissement GAI SA
PAR:MLGAI
|
FR |
|
I
|
Integrity Technology Group Inc
SSE:688244
|
CN |
|
X
|
Xiamen R&T Plumbing Technology Co Ltd
SZSE:002790
|
CN |
|
S
|
Sunzen Biotech Bhd
KLSE:SUNZEN
|
MY |
|
C
|
Cambi ASA
OSE:CAMBI
|
NO |
|
O
|
Orangekloud Technology Inc
NASDAQ:ORKT
|
SG |
|
S
|
SDI Group PLC
LSE:SDI
|
UK |
|
F
|
Fujian Zhangzhou Development Co Ltd
SZSE:000753
|
CN |
|
G
|
Gaming Innovation Group Inc
OSE:GIG
|
MT |
|
M
|
Metro Global Media Inc
OTC:MGMA
|
US |
|
Eurobio Scientific SA
PAR:ALERS
|
FR |
|
M
|
Marex Group PLC
NASDAQ:MRX
|
UK |
|
Erasca Inc
NASDAQ:ERAS
|
US |
|
D
|
DistIT AB
STO:DIST
|
SE |
Relative Value
The Relative Value of one
Solasia Pharma KK
stock under the Base Case scenario is
hidden
JPY.
Compared to the current market price of 32 JPY,
Solasia Pharma KK
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Solasia Pharma KK Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Solasia Pharma KK Competitors
Solasia Pharma KK Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| JP |
|
Solasia Pharma KK
TSE:4597
|
8.4B JPY | 19.6 | -9.6 | -8.8 | -8.4 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.5B USD | 5.9 | 86.6 | 14.4 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.3B USD | 5.8 | 20 | 12.5 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.3B USD | 9.6 | 29.2 | 21.9 | 22.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.5B USD | 5.4 | 17.2 | 12.6 | 14.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.8B AUD | 3.1 | 33.9 | 11.2 | 14.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
41.3B USD | 11.1 | 131.9 | 73.8 | 82 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
